Alzheimer's Drug Discovery Foundation Funds Development Of Clinical Tests For Alzheimer's Disease
The Alzheimer's Drug Discovery Foundation (ADDF) awarded the British firm of Cambridge Cognition Ltd. a grant of $200,000 to assist in their development of a clinical cognitive assessment product for Alzheimer's disease.
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment